Total Payments
$13,964
2024 Payments
$841.74
Companies
27
Transactions
234
Medicare Patients
6,080
Medicare Billing
$2.0M
Payment Breakdown by Category
Consulting$7,800 (55.9%)
Food & Beverage$3,782 (27.1%)
Other$2,250 (16.1%)
Education$132.88 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,800 | 11 | 55.9% |
| Food and Beverage | $3,782 | 212 | 27.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,250 | 1 | 16.1% |
| Education | $132.88 | 10 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Outset Medical Inc | $10,050 | 12 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $839.05 | 46 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $389.02 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $381.12 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $269.33 | 16 | $0 (2024) |
| Vifor Pharma, Inc. | $244.93 | 13 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $244.57 | 13 | $0 (2022) |
| Amgen Inc. | $205.64 | 12 | $0 (2022) |
| Relypsa, Inc. | $193.86 | 14 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $178.40 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $841.74 | 46 | AstraZeneca Pharmaceuticals LP ($240.43) |
| 2023 | $737.07 | 39 | Calliditas Therapeutics US Inc. ($163.85) |
| 2022 | $2,939 | 39 | Outset Medical Inc ($2,250) |
| 2021 | $3,819 | 27 | Outset Medical Inc ($3,500) |
| 2020 | $2,559 | 14 | Outset Medical Inc ($2,400) |
| 2019 | $2,446 | 32 | Outset Medical Inc ($1,900) |
| 2018 | $268.24 | 17 | Amgen Inc. ($50.09) |
| 2017 | $354.68 | 20 | Relypsa, Inc. ($83.18) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Diabetes | ||||||
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Nephrology | ||||||
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.77 | General |
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Nephrology | ||||||
| 09/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 08/27/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Hyperkalemia | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: DIABETES | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Nephrology | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.17 | General |
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: DIABETES | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.31 | General |
| 07/10/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Nephrology | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,307 | 5,191 | $919,959 | $400,228 |
| 2022 | 17 | 1,394 | 5,932 | $1.1M | $452,556 |
| 2021 | 17 | 1,557 | 5,871 | $1.2M | $583,755 |
| 2020 | 18 | 1,822 | 7,692 | $1.5M | $607,079 |
Total Patients
6,080
Total Services
24,686
Medicare Billing
$2.0M
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 112 | 794 | $460,520 | $209,239 | 45.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 237 | 913 | $109,560 | $54,689 | 49.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 81 | 169 | $87,880 | $36,903 | 42.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 19 | 127 | $73,660 | $27,158 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 346 | $60,896 | $19,436 | 31.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 165 | 188 | $34,216 | $17,747 | 51.9% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 15 | 2,035 | $24,420 | $11,852 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 124 | $13,640 | $5,771 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $8,600 | $4,286 | 49.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 75 | 75 | $15,000 | $3,595 | 24.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 13 | 21 | $10,185 | $3,220 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $4,928 | $2,027 | 41.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 19 | 19 | $6,650 | $1,796 | 27.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 116 | $4,524 | $1,172 | 25.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 13 | 16 | $3,168 | $864.86 | 27.3% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 12 | 97 | $1,164 | $225.04 | 19.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 68 | 68 | $816.00 | $221.65 | 27.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 11 | $132.00 | $24.20 | 18.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 136 | 888 | $514,980 | $239,757 | 46.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 248 | 972 | $116,640 | $52,666 | 45.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 90 | 194 | $100,880 | $43,137 | 42.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 24 | 182 | $105,560 | $40,418 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 300 | 474 | $83,424 | $19,408 | 23.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 167 | 186 | $33,852 | $18,520 | 54.7% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2022 | 17 | 2,349 | $28,188 | $14,503 | 51.5% |
About Dr. Reginald Gladish, MD
Dr. Reginald Gladish, MD is a Nephrology healthcare provider based in Decatur, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831167287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reginald Gladish, MD has received a total of $13,964 in payments from pharmaceutical and medical device companies, with $841.74 received in 2024. These payments were reported across 234 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($7,800).
As a Medicare-enrolled provider, Gladish has provided services to 6,080 Medicare beneficiaries, totaling 24,686 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Decatur, AL
- Active Since 03/10/2006
- Last Updated 02/18/2008
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1831167287
Products in Payments
- Veltassa (Drug) $409.41
- TARPEYO (Drug) $389.02
- FARXIGA (Drug) $362.94
- JARDIANCE (Drug) $337.35
- LOKELMA (Drug) $273.91
- Kerendia (Drug) $269.33
- JYNARQUE (Drug) $196.26
- SAMSCA (Drug) $184.86
- Rayaldee (Drug) $153.36
- Auryxia (Drug) $128.71
- Parsabiv (Biological) $104.30
- RAYALDEE (Drug) $91.21
- BENLYSTA (Biological) $73.98
- Renal - PD (Device) $66.69
- ACTHAR (Biological) $65.00
- Parsabiv (Drug) $64.12
- IBSRELA (Drug) $63.79
- Velphoro (Drug) $50.44
- Rituxan (Biological) $46.88
- AURYXIA (Drug) $45.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Decatur
Aliya Saeed, M.d, M.D
Nephrology — Payments: $2,091
Nephrology $2,091
Dr. Mohammed Dawood, M.d, M.D
Nephrology — Payments: $1,667
Nephrology $1,667
Dr. Muhammad Qureshi, Md, MD
Nephrology — Payments: $1,261
Nephrology $1,261
Dr. Mohammad Hasnain, M.d, M.D
Nephrology — Payments: $810.29
Nephrology $810.29
Dr. Faryal Niazi, M.d, M.D
Nephrology — Payments: $514.67
Nephrology $514.67
Andrew Dixon, M.d, M.D
Nephrology — Payments: $501.24
Nephrology $501.24